Bedford, MA – According to filings with the U.S. Securities and Exchange Commission, Access Vascular Inc. is raising $7,257,884.00 in a new round of investment. Sources indicate as part of senior management President, James Biggins played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Access Vascular Inc.

Access Vascular is developing a suite of venous access devices that use our novel, patented biomaterial which is designed to prevent the most common and costly complications in venous access. Our first product, FDA-cleared HydroPICC, has demonstrated a 30x reduction in thrombosis versus a standard polyurethane catheter.

To learn more about Access Vascular Inc., visit http://www.accessvascularinc.com/

Contact:
James Biggins, President
781-538-6594
https://www.linkedin.com/in/jamesbiggins/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved